Presentation Information
[P9-01]Efficacy and Safety of Perampanel as Monotherapy in Subjects with Focal Onset Seizures at 12 Months and Analysis by Dose
○Shinsuke Maruyama1, Hideaki Kanemura2, Shohei Nishimoto3, Karin Tanaka3, Taisei Tsuruda3, Naoki Akamatsu4 (1.Department of Pediatrics, Kagoshima University Hospital, Kagoshima, Japan, 2.Department of Pediatrics, Toho University Sakura Medical Center, Chiba, Japan, 3.Medical Headquarters, Eisai Co., Ltd., Tokyo, Japan, 4.Department of Neurology, International University of Health and Welfare, Chiba, Japan)